Health and wellness influencers are advertising carbon dioxide inhalers as treatment for an array of medical conditions in posts -- some which include homophobic language -- that have been viewed ...
Earnings call Zydus Lifesciences delivered 20% YoY revenue growth to ₹52.4B in Q2 FY25, with EBITDA up 28% and margins expanding 170 bps to 27.9%. U.S. revenues surged 30% YoY, and India branded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results